David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world's most threatening infectious diseases. The company's lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax's […]The post SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax appeared first on Business RadioX ®.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More